New Delhi, July 15 (IANS) The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with the Uttar Pradesh Promote Pharma Council (UPPPC) to strengthen quality standards, regulatory compliance and innovation in the pharmaceutical and medical device sectors, it was announced on Wednesday.The Ministry of Health and Family Welfare said that the agreement was signed during the YEIDA MedTech Investors Meet and Site Visit 2026, held at the India Expo Mart.The strategic p…
Latest Indian Pharmacopoeia Commission News & Updates
New Delhi, June 18 (IANS) The standards of the Indian Pharmacopoeia are comparable with leading international pharmacopoeias, and the country has been recognised for its leadership in developing and establishing quality standards for several medicines, the government said on Thursday.A delegation from the Indian Pharmacopoeia Commission (IPC) led by Dr V Kalaiselvan, Secretary-cum-Scientific Director, along with Dr Pawan Saini and Dr Shruti Rastogi, participated in the 16th International Meeting…
New Delhi, June 11 (IANS) A scientific conclave and interactive session on the Indian Pharmacopoeia (IP) 2026 was held in Haridwar to raise awareness of new provisions under IP and promote quality compliance across the pharmaceutical manufacturing sector, the government said on Thursday.Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, organised the conclave, in collaboration with the Association of Devbhumi Pharma Industries and af…
New Delhi, April 24 (IANS) The Central government’s Indian Pharmacopoeia Commission has signed two memoranda of understandings (MoU) with two government institutes to strengthen quality assurance, ensure rational use of medicines, pharmacovigilance and collaborative research, an official statement said on Friday.One MoU with the Pharmaceuticals & Medical Devices Bureau of India aims to enhance the quality assurance framework for medicines made available through Pradhan Mantri Bhartiya Janaus…
New Delhi, April 15 (IANS) Healthcare companies in India are expected to deliver high single-digit revenue growth (year-on-year) in the fourth quarter of FY26 (Q4 FY26), a report showed on Wednesday.However, EBITDA margins will materially be corrected, according to the report by Systematix.“Median growth is estimated at 12 per cent for revenue and 3.6 per cent for EBTIDA, with net earnings likely witnessing a 14 per cent decline, the report mentioned.The primary driver of this on-year decline …
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.Reports said that the move under a draft of the National Formulary of India (NFI) 2026, released by the Indian Pharmacopoeia Commission, marks a notable shift in prescribing norms after a series of contamination-linked deaths last year.There was, however, no official word from Health Ministry on the repo…
New Delhi, April 4 (IANS) India’s drug regulators are stepping up oversight of fast-growing weight-loss and diabetes therapies, particularly GLP-1 receptor agonists, amid rising demand and the anticipated entry of cheaper generic versions into the domestic market.The move comes as the Indian Pharmacopoeia Commission (IPC), which functions under the Ministry of Health, has been tasked with systematically collecting and analysing adverse event reports linked to these drugs.The initiative aims to…
New Delhi, Jan 2 (IANS) India has risen to 8th position globally from 123rd in the World Health Organization’s (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.He was speaking at the release of the Indian Pharmacopoeia 2026 (IP 2026) – the 10th edition of India’s official book of drug standards, at an event held at the Dr. Ambedkar International Centre, New Delhi.“The Indian Pharmacopoeia serves as the official book of standards…
New Delhi, Dec 26 (IANS) Union Health Minister JP Nadda on Friday undertook a review of the progress of Indian Pharmacopoeia Commission to ensure the quality of medicines.Pharmacovigilance by IPC plays a major role in safeguarding patient health. The body regulates the quality, safety, and efficacy of the India-made medicines for both the domestic and global markets.Nadda stated that the efforts signal the country’s growing scientific self-reliance. The meeting was themed ‘advancing towards Viks…